Rockwell Medical Inc (RMTI)
1.505
+0.02
(+1.01%)
USD |
NASDAQ |
Apr 25, 13:42
Rockwell Medical Total Assets (Quarterly): 52.17M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 52.17M |
| September 30, 2023 | 52.61M |
| June 30, 2023 | 38.04M |
| March 31, 2023 | 40.47M |
| December 31, 2022 | 46.64M |
| September 30, 2022 | 54.19M |
| June 30, 2022 | 59.12M |
| March 31, 2022 | 37.44M |
| December 31, 2021 | 48.57M |
| September 30, 2021 | 58.70M |
| June 30, 2021 | 63.68M |
| March 31, 2021 | 69.45M |
| December 31, 2020 | 77.75M |
| September 30, 2020 | 85.24M |
| June 30, 2020 | 58.58M |
| March 31, 2020 | 66.83M |
| December 31, 2019 | 44.32M |
| September 30, 2019 | 48.09M |
| June 30, 2019 | 57.08M |
| March 31, 2019 | 48.75M |
| December 31, 2018 | 52.56M |
| September 30, 2018 | 38.08M |
| June 30, 2018 | 41.42M |
| March 31, 2018 | 51.96M |
| December 31, 2017 | 58.78M |
| Date | Value |
|---|---|
| September 30, 2017 | 65.81M |
| June 30, 2017 | 69.48M |
| March 31, 2017 | 80.46M |
| December 31, 2016 | 83.15M |
| September 30, 2016 | 82.85M |
| June 30, 2016 | 87.14M |
| March 31, 2016 | 89.10M |
| December 31, 2015 | 87.82M |
| September 30, 2015 | 90.92M |
| June 30, 2015 | 91.53M |
| March 31, 2015 | 97.16M |
| December 31, 2014 | 98.00M |
| September 30, 2014 | 23.87M |
| June 30, 2014 | 25.88M |
| March 31, 2014 | 26.79M |
| December 31, 2013 | 36.36M |
| September 30, 2013 | 43.60M |
| June 30, 2013 | 54.03M |
| March 31, 2013 | 17.97M |
| December 31, 2012 | 17.03M |
| September 30, 2012 | 24.22M |
| June 30, 2012 | 34.09M |
| March 31, 2012 | 39.42M |
| December 31, 2011 | 31.94M |
| September 30, 2011 | 34.59M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
37.44M
Minimum
Mar 2022
85.24M
Maximum
Sep 2020
55.73M
Average
54.19M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 8.805M |
| Oragenics Inc | 4.966M |
| Alpine Immune Sciences Inc | 379.85M |
| Corvus Pharmaceuticals Inc | 45.55M |
| MAIA Biotechnology Inc | 7.567M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 30.88M |
| Shareholders Equity (Quarterly) | 21.29M |
| Debt to Equity Ratio | 0.401 |
| Current Ratio | 1.729 |
| Net Debt Paydown Yield | 2.38% |